Skip to main content
SpringerLink
Log in

Renale Denervation bei therapierefraktärer arterieller Hypertonie verfehlt in der SYMPLICITY-HTN-3-Studie den primären Wirksamkeitsendpunkt

Renal devervation for therapy resistant arterial hypertension fails to achieve the primary effectiveness endpoint in the Symplicity HTN-3 study

  • Journal Club
  • Published:
Der Kardiologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Schlaich MP, Sobotka PA, Krum H et al (2009) Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361:932–934

    Article  CAS  PubMed  Google Scholar 

  2. Bhatt DL, Kandzari DE, O’Neill WW et al (2014) A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370:1393–1401

    Article  CAS  PubMed  Google Scholar 

  3. Krum H, Schlaich MP, Sobotka PA et al (2014) Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet 383:622–629

    Article  PubMed  Google Scholar 

  4. Symplicity HTNI, Esler MD, Krum H et al (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376:1903–1909

    Article  Google Scholar 

  5. Messerli FH, Bangalore S (2014) Renal denervation for resistant hypertension? N Engl J Med 370:1454–1457

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt

C. Özcelik gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Herzverbund Südniedersachsen, Helios Albert-Schweitzer-Klinik, Sturmbäume 8, 37154, Northeim, Deutschland

    C. Özcelik

Authors
  1. C. Özcelik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Özcelik.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Özcelik, C. Renale Denervation bei therapierefraktärer arterieller Hypertonie verfehlt in der SYMPLICITY-HTN-3-Studie den primären Wirksamkeitsendpunkt. Kardiologe 8, 214–215 (2014). https://doi.org/10.1007/s12181-014-0574-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-014-0574-z

Search

Navigation